Top compounds associated with response to C11orf98


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.02
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC -0.079 0.02
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.081 0.02
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.02
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.02
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.03
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.082 0.03
mRNA LY-2157299 CTRPv2 pan-cancer AAC -0.17 0.03
mRNA marinopyrrole A CTRPv2 pan-cancer AAC 0.096 0.03
mRNA ML083 CTRPv2 pan-cancer AAC -0.084 0.03
Download CSV